ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 51 filers reported holding ELOXX PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $377,000 | -13.3% | 113,477 | +3.8% | 0.00% | – |
| Q4 2020 | $435,000 | +53.7% | 109,297 | +1.4% | 0.00% | – |
| Q3 2020 | $283,000 | -20.3% | 107,781 | -8.0% | 0.00% | – |
| Q2 2020 | $355,000 | +54.3% | 117,187 | +0.1% | 0.00% | – |
| Q1 2020 | $230,000 | -67.5% | 117,080 | +21.9% | 0.00% | – |
| Q4 2019 | $707,000 | +32.1% | 96,042 | -18.9% | 0.00% | – |
| Q3 2019 | $535,000 | -41.6% | 118,446 | +29.0% | 0.00% | – |
| Q2 2019 | $916,000 | – | 91,794 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Clal Insurance Enterprises Holdings Ltd | 14,626 | $27 | 0.00% |